EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control

Briana E Price, Ryan Kuesel, Taylor Reams, Brian Manley, James Masucci, Brandon K Hopkins

Pest Management Science · 2026-10 · 82 (10) · 9974-9983

DOI: 10.1002/ps.71032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pest Management Science, online erschienen am 29.06.2026. Verfasst von Briana E Price und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Entomology, Washington State University, Pullman, WA, USA. Hauptthemen laut MEDLINE: Varroidae, RNA, Double-Stranded, Pest Control, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Greenlight Biosciences Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND A novel dsRNA‐based product, containing a molecule called vadescana, interferes with Varroa destructor (Anderson and Trueman) fecundity and shows promise as a new biopesticide strategy for Varroa management. This study defines optimal dosing rates for vadescana in the field by evaluating efficacy in full‐sized honey bee ( Apis mellifera Linneas) hives to contribute essential preliminary information for vadescana development and implementation. Additionally, this study examined the impacts of various doses of vadescana on colony health by counting frames of bees and brood. RESULTS Various concentrations, application volumes, and regimens (single or split application 3 weeks apart) of vadescana (2, 4, or 8 g/L) were applied to colonies and impacts were compared to colonies left untreated or treated with amitraz (positive control). Vadescana (4 g/L) applied at 4 g per brood box in a single dose was most effective at reducing Varroa populations for up to 18 weeks. Colony populations (average number of frames of bees and brood) remained unaffected among treatments over time. CONCLUSION The results presented provide critical information for the development of vadescana by defining an optimal dose to use in full‐size honey bee colonies and supporting claims of insignificant honey bee colony‐level impacts. This study also introduces further research needs for broader applications and future deployment of this dsRNA‐based Varroa management option. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VarroidaeRNA, Double-StrandedPest Control, BiologicalAnimalsBeesDose-Response Relationship, DrugAcaricides

Stichwörter der Autor:innen

Apis melliferaRNA interferenceVarroabiopesticidedose–responsevadescana

Substanzen

RNA, Double-StrandedAcaricides

Autor:innen und Institutionen

  • Department of Entomology, Washington State University, Pullman, WA, USA.
  • GreenLight Biosciences, Research Triangle Park, Durham, NC, USA.

Förderung

  • Greenlight Biosciences Inc.

Zitieren

APA

Price, B. E., Kuesel, R., Reams, T., Manley, B., Masucci, J., & Hopkins, B. K. (2026). Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control. Pest Management Science, 82(10), 9974-9983. https://doi.org/10.1002/ps.71032

Vancouver

Price BE, Kuesel R, Reams T, Manley B, Masucci J, Hopkins BK. Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control. Pest Management Science. 2026;82(10):9974-9983. doi:10.1002/ps.71032

BibTeX
@article{Price2026,
  author = {Price, Briana E and Kuesel, Ryan and Reams, Taylor and Manley, Brian and Masucci, James and Hopkins, Brandon K},
  title = {Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control},
  journal = {Pest Management Science},
  year = {2026},
  volume = {82},
  number = {10},
  pages = {9974--9983},
  doi = {10.1002/ps.71032}
}
Kostenlos starten →